Re: Padeliporfin Vascular-Targeted Photodynamic Therapy versus Active Surveillance in Men with Low-Risk Prostate Cancer (CLIN1001 PCM301): An Open-Label, Phase 3, Randomised Controlled Trial

Samir S. Taneja

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)255-257
Number of pages3
JournalThe Journal of urology
Issue number2
StatePublished - Aug 1 2017

ASJC Scopus subject areas

  • Urology

Cite this